Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Selection And Characterization Of DNA Aptamers Targeting All Four Serotypes Of Dengue Viruses

Heng-Li Chen, Wen-Hsin Hsiao, Hsiang-Chi Lee, S. Wu, J. Cheng
Published 2015 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Dengue viruses (DENVs) are members of Flaviviridae family, which are associated with human disease. The envelope (E) protein plays an important role in viral infection. However, there is no effective antibody for clinical treatment due to antibody dependent enhancement of infection. In this study, using Systematic Evolution of Ligands by Exponential Enrichment (SELEX), we demonstrated the first aptamer (S15) that can bind to DENV-2 envelop protein domain III (ED3) with a high binding affinity. S15 was found to form a parallel quadruplex based on Quadfinder prediction, gel mobility assay and circular dichroism studies. Both the quadruplex structure and the sequence on 5’-end were necessary for the binding activity of S15. NMR titration experiments indicated that S15 bound to a highly conserved loop between βA and βB strands of ED3. Moreover, S15 can neutralize the infections by all four serotypes of DENVs. Our result provides a new opportunity in the development of DNA aptamers against DENVs in the future.
This paper references
10.1186/1743-422X-2-49
Peptide inhibitors of dengue virus and West Nile virus infectivity
Yancey Hrobowski (2005)
10.1038/nsmb.1382
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins
S. Lok (2008)
10.1073/PNAS.90.8.3745
Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution.
R. Macaya (1993)
10.1038/375291A0
The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
F. Rey (1995)
10.1084/JEM.146.1.201
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
SB Halstead (1977)
10.1007/s00430-007-0043-4
Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice
Alka (2007)
10.1128/JVI.00432-07
Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes
Soila Sukupolvi-Petty (2007)
10.1016/0166-0934(96)02096-4
J. Virol. Methods: Corrigendum to “Detection of stylet-borne and circulative potato viruses in aphids by duplex reverse transcription polymerase chain reaction” [59 (1996) 189]
R. P. Singh (1996)
10.1093/nar/gkl253
QGRS Mapper: a web-based server for predicting G-quadruplexes in nucleotide sequences
Oleg Kikin (2006)
10.1016/J.BIOS.2006.09.015
In vitro selection of DNA aptamer against abrin toxin and aptamer-based abrin direct detection.
Jijun Tang (2007)
10.1016/j.vaccine.2007.12.047
Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen.
A. C. N. Sim (2008)
10.1016/j.virol.2008.11.013
Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
K. Matsui (2009)
10.1186/1471-2172-7-7
CED: a conformational epitope database
J. Huang (2006)
10.1093/NAR/GNG110
An improved method for the in vitro evolution of aptamers and applications in protein detection and purification.
Michael B Murphy (2003)
10.1056/NEJMoa1411037
Efficacy of a tetravalent dengue vaccine in children in Latin America.
L. Villar (2015)
10.1038/346818A0
In vitro selection of RNA molecules that bind specific ligands
A. Ellington (1990)
10.1099/0022-1317-77-10-2541
A single nucleotide change in the E protein gene of dengue virus 2 Mexican strain affects neurovirulence in mice.
I. Sánchez (1996)
10.1016/J.BBRC.2005.10.172
In vitro selection of DNA aptamers binding ethanolamine.
D. Mann (2005)
A plaque reduction test for dengue virus neutralizing antibodies.
P. K. Russell (1967)
10.1073/PNAS.0406278102
An interlocked dimeric parallel-stranded DNA quadruplex: a potent inhibitor of HIV-1 integrase.
A. Phan (2005)
HondaW. CED: a conformational epitope database
J Huang (2006)
10.1093/NAR/20.15.4061
Hairpin and parallel quartet structures for telomeric sequences.
P. Balagurumoorthy (1992)
10.1093/NAR/GKG748
Selective inhibitory DNA aptamers of the human RNase H1.
F. Pileur (2003)
10.1016/j.febslet.2007.03.012
A proline to glycine mutation in the Lck SH3‐domain affects conformational sampling and increases ligand binding affinity
F. Bauer (2007)
10.1093/nar/gkp647
Unique quadruplex structure and interaction of an RNA aptamer against bovine prion protein
T. Mashima (2009)
HondaW. CED: a conformational epitope database
J Huang (2006)
10.1073/pnas.0832193100
A ligand-binding pocket in the dengue virus envelope glycoprotein
Y. Modis (2003)
10.1128/JVI.79.2.1223-1231.2005
Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein
Y. Modis (2005)
10.1093/nar/gki345
Vertebrate telomere repeat DNAs favor external loop propeller quadruplex structures in the presence of high concentrations of potassium
Iulian N. Rujan (2005)
10.1016/J.BBRC.2006.03.144
The thrombin binding aptamer GGTTGGTGTGGTTGG forms a bimolecular guanine tetraplex.
M. Fialová (2006)
10.1099/0022-1317-78-11-2711
The molecular basis of virulence of the encephalitogenic flaviviruses.
P. McMinn (1997)
Characterization of dengue complexreactive epitopes on dengue 3 virus envelope protein domain III. Virology
K Matsui (2008)
10.1021/ac701962v
Identification of liver cancer-specific aptamers using whole live cells.
Dihua Shangguan (2008)
10.1016/J.BBRC.2007.04.007
Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis.
F. Chen (2007)
10.1038/nature02165
Structure of the dengue virus envelope protein after membrane fusion
Y. Modis (2004)
10.1016/j.vaccine.2007.10.055
Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus
B. Martina (2008)
10.1007/S00216-006-0826-2
Methods developed for SELEX
S. C. Gopinath (2007)
10.1126/SCIENCE.2200121
Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.
C. Tuerk (1990)
10.1128/JVI.74.20.9601-9609.2000
Attenuation of Tick-Borne Encephalitis Virus by Structure-Based Site-Specific Mutagenesis of a Putative Flavivirus Receptor Binding Site
C. Mandl (2000)
10.1128/JVI.02724-07
A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus
K. Raviprakash (2008)
10.1016/J.MICINF.2006.09.009
The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry.
J. L. Chin (2007)
10.1128/JVI.00606-08
Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus
Gregory D. Gromowski (2008)
10.1016/J.JVIROMET.2007.02.012
High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.
Zhi-shan Zhang (2007)
10.1093/nar/gkn891
Novel bimodular DNA aptamers with guanosine quadruplexes inhibit phylogenetically diverse HIV-1 reverse transcriptases
D. Michalowski (2008)
10.1099/VIR.0.80411-0
Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.
J. J. Chu (2005)
10.1002/prot.21806
Solution structure and neutralizing antibody binding studies of domain III of the dengue‐2 virus envelope protein
K. Huang (2008)
10.1016/j.cell.2005.11.042
Cryo-EM Reconstruction of Dengue Virus in Complex with the Carbohydrate Recognition Domain of DC-SIGN
E. Pokidysheva (2006)
10.1128/CMR.11.3.480
Dengue and Dengue Hemorrhagic Fever
D. Gubler (1998)
10.1038/nbt0604-649
Oligo oligarchy—the surprisingly small world of aptamers
K. Thiel (2004)
10.1128/JVI.75.16.7769-7773.2001
Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells
W. Crill (2001)
10.1038/nrmicro1690
Prospects for a dengue virus vaccine
S. Whitehead (2007)
10.1016/S0039-9140(98)00198-2
Investigation of the interaction between acridine orange and bovine serum albumin.
X. Z. Feng (1998)
10.1097/00006454-199204000-00010
Dengue and dengue hemorrhagic fever.
D. Gubler (1998)



This paper is referenced by
10.3390/ph9040078
Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses
V. M. González (2016)
10.1039/C6CC07552E
Structural regulation by a G-quadruplex ligand increases binding abilities of G-quadruplex-forming aptamers.
Kaori Tsukakoshi (2016)
10.3390/ph10020044
Pathogenesis and Inhibition of Flaviviruses from a Carbohydrate Perspective
S. Kim (2017)
10.1016/j.talanta.2019.01.058
A new immunoassay of hybrid nanomater conjugated to aptamers for the detection of dengue virus.
C. R. Basso (2019)
10.5772/INTECHOPEN.84867
Aptamers for Diagnostics with Applications for Infectious Diseases
M. Ilgu (2019)
10.3390/biomedicines5030054
Engineered Aptamers to Probe Molecular Interactions on the Cell Surface
Sana Batool (2017)
10.1038/s41557-019-0369-8
Designer DNA architecture offers precise and multivalent spatial pattern-recognition for viral sensing and inhibition
Paul S. Kwon (2019)
10.4155/fmc-2016-0233
Characterization of oligonucleotide aptamers targeting the 5'-UTR from dengue virus.
Elismar Jn Cnossen (2017)
10.1016/j.ab.2018.06.015
An efficient method to evaluate experimental factor influence on in vitro binding of aptamers.
Donglin Diao (2018)
10.3390/pharmaceutics12070646
Current Perspectives on Aptamers as Diagnostic Tools and Therapeutic Agents
Prabir Kumar Kulabhusan (2020)
10.3389/fmicb.2019.01462
Application of Aptamers in Virus Detection and Antiviral Therapy
Xinran Zou (2019)
10.1016/j.jinf.2018.04.007
Oligonucleotide aptamers: promising and powerful diagnostic and therapeutic tools for infectious diseases
Q. Pan (2018)
10.1016/j.biotechadv.2017.01.003
ABCs of DNA aptamer and related assay development.
Tarun Kumar Sharma (2017)
10.5772/INTECHOPEN.86945
Aptamers for Infectious Disease Diagnosis
Soma Banerjee (2019)
10.1007/s12250-020-00236-z
A DNA Aptamer Based Method for Detection of SARS-CoV-2 Nucleocapsid Protein
Z. Chen (2020)
10.1016/j.biotechadv.2016.02.003
Aptamer-based 'point-of-care testing'.
S. Gopinath (2016)
10.1101/608380
Designer DNA architecture offers precise and multivalent spatial pattern-recognition for viral sensing and inhibition
Paul S Kwon (2019)
Aptamer as a Targeted Drug Delivery
Mayur Sadar (2020)
10.3390/ijms22010159
Application of Aptamer-Based Assays to the Diagnosis of Arboviruses Important for Public Health in Brazil
A. P. Argondizzo (2020)
Semantic Scholar Logo Some data provided by SemanticScholar